- Home
- / Shockwave Medical
Shockwave Medical
Patients Tested to Date
179
Feb, 2019
Revenue
$237.1 M
FY, 2021
Market Capitalization
$6.2 B
2023-01-19
Shockwave Medical Summary
Company summary
- Overview
- Shockwave Medical is a company developing interventional therapy for calcified cardiovascular disease. It provides the Lithoplasty balloon dilatation catheters. The company also offers intravascular lithotripsy, a novel treatment option that allows calcium modification.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Santa Clara, CA, US | view all locations
- Website
- http://shockwavemedical.com/
- Cybersecurity rating
- ESG rating
Key people
Isaac Zacharias, President & Chief Commercial Officer
Dan Puckett, CFO
Beaux Alexander, VP of Clinical Affairs
Operating MetricsView all
Patients Tested to Date
179
Feb, 2019
LocationsView all
2 locations detected
Santa Clara, CA HQ
United States
5403 Betsy Ross Dr
Kleve, NRW
Germany
Siemensstraße 31
Shockwave Medical Financials
Summary financials
- Revenue (Q3, 2022)
- $131.3M
- Gross profit (Q3, 2022)
- $113.5M
- Net income (Q3, 2022)
- $35.0M
- Cash (Q3, 2022)
- $127.8M
- EBIT (Q3, 2022)
- $36.8M
- Enterprise value
- $6.1B
